These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 19153853

  • 1. Preparation of crotaline F-ab antivenom (CroFab) with automated mixing methods: in vitro observations.
    Vohra R, Kelner M, Clark RF.
    Clin Toxicol (Phila); 2009 Jan; 47(1):69-71. PubMed ID: 19153853
    [Abstract] [Full Text] [Related]

  • 2. CroFab reconstitution in various media: an in vitro solubility study.
    Vohra R, Clark R, Kelner M.
    Clin Toxicol (Phila); 2008 Nov; 46(9):808-10. PubMed ID: 18821147
    [Abstract] [Full Text] [Related]

  • 3. Validating a faster method for reconstitution of Crotalidae Polyvalent Immune Fab (ovine).
    Gerring D, King TR, Branton R.
    Toxicon; 2013 Jul; 69():42-9. PubMed ID: 23305624
    [Abstract] [Full Text] [Related]

  • 4. Improving Crotalidae polyvalent immune Fab reconstitution times.
    Quan AN, Quan D, Curry SC.
    Am J Emerg Med; 2010 Jun; 28(5):593-5. PubMed ID: 20579555
    [Abstract] [Full Text] [Related]

  • 5. Crotalidae polyvalent immune Fab antivenom limits the decrease in perfusion pressure of the anterior leg compartment in a porcine crotaline envenomation model.
    Tanen DA, Danish DC, Clark RF.
    Ann Emerg Med; 2003 Mar; 41(3):384-90. PubMed ID: 12605206
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Acute hypersensitivity reactions associated with administration of crotalidae polyvalent immune Fab antivenom.
    Cannon R, Ruha AM, Kashani J.
    Ann Emerg Med; 2008 Apr; 51(4):407-11. PubMed ID: 18191286
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The implications of regulatory guidelines on allergen vial mixing for the practicing otolaryngologist.
    Lin SY, Houser SM, Rodriguez HP.
    Otolaryngol Head Neck Surg; 2007 Apr; 136(4):658-9. PubMed ID: 17418269
    [Abstract] [Full Text] [Related]

  • 14. Comparison of seven methods of preparing and administering cefazolin sodium small-volume injections.
    Smith TF, Kitrenos JG.
    Am J Hosp Pharm; 1986 Aug; 43(8):1930-5. PubMed ID: 3752132
    [Abstract] [Full Text] [Related]

  • 15. Time to reconstitution: purified Fab antivenom vs. unpurified IgG antivenom.
    Hill RE, Bogdan GM, Dart RC.
    Toxicon; 2001 May; 39(5):729-31. PubMed ID: 11072054
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The implications of regulatory guidelines on allergen vial mixing for the practicing otolaryngologist.
    Lin SY, Houser SM, Rodriguez HP.
    Otolaryngol Head Neck Surg; 2007 Jun; 136(6):1017-1018. PubMed ID: 17547999
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.